Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CARE | BLMN |
|---|---|---|
| Price | $30.19 | $8.27 |
| Change today | ▲ 0.00% | ▲ 1.16% |
| Market cap | $699.32M | $707.66M |
| Return, 3 months | -6.4% | +2.5% |
| Return, year to date | +54.6% | +34.0% |
| Return, 1 year | +56.5% | +9.6% |
| P/E (TTM) | 5.2 | 25.8 |
| P/B | 1.3 | 1.6 |
| P/E percentile vs own 5y | 3rd | 73rd |
| Dividend yield | 0.33% | 1.81% |
| Revenue growth (YoY, latest qtr) | -12.7% | +1.3% |
| Net profit growth (YoY) | +239.7% | +22.2% |
| Gross margin | – | 13.4% |
| Operating margin | – | 3.2% |
| Net margin | 59.4% | 0.7% |
| Return on equity | 26.9% | 6.7% |
| Analyst target vs. price | +14.3% | +42.3% |
| Analyst buy share | 0% | 0% |
| RSI (14) | 43 | 42 |
| 30-day volatility | 19.7% | 58.0% |
| Max drawdown, 1 year | -16.7% | -34.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
